𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pulsed–dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer

✍ Scribed by Matthias Geiger; Vratislav Strnad; Michael Lotter; Rolf Sauer

Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
131 KB
Volume
1
Category
Article
ISSN
1538-4721

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interstitial high-dose-rate brachytherap
Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer
✍ Antonio Cassio Assis Pellizzon; Paulo Eduardo Ribeiro dos Santos Novaes; Maria A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract ## Background. The literature is scarce regarding the use of interstitial high‐dose‐rate brachytherapy (I‐HDR) as adjuvant treatment of the cervical region, and most reports are focused on primary tumors of the mobile tongue and oropharynx. We evaluated the outcome and morbidity relate

Interstitial low-dose-rate brachytherapy
Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies
✍ Laval Grimard; Bernd Esche; André Lamothe; Joanna Cygler; Johanna Spaans 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

Background. Recurrent head and neck malignancies are therapeutically challenging. Brachytherapy is a retreatment alternative to external-beam radiation therapy (EBRT). Methods. Patients receiving brachytherapy during 1987-2004 for recurrent head and neck cancer were identified. Tumor and treatment

The role of interstitial brachytherapy w
The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers
✍ Michael E. Kupferman; William H. Morrison; Alfredo A. Santillan; Dianna Roberts; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 2 views

## Abstract ## BACKGROUND The role of interstitial brachytherapy (IBT) in the salvage surgical management of regional lymphatic metastases for head and neck cancer has not been defined to date. To further explore its therapeutic benefit in the management of head and neck squamous cell carcinoma, t